Dr Mingliang Chen
Mingliang Chen, born in 1983, Shanghai, China. I acquired my degrees of B.S., M.S. and Ph.D. in Fudan University, specialising in Pathogenic Biology. I have been working in Department of Microbiology in Shanghai CDC since 2007 and became an associate senior technician in 2017. My work is to perform laboratory surveillance of respiratory pathogenic bacteria, such as Meningococcus, Streptococcus, and Legionella, focused on molecular typing and antibiotic resistance. I have studied in Maiden Lab from March to December of 2017, learning skills of analyzing meningococcal genomes.
Research interests
These include clonal dissemination and origin of quinolone-resistance among meningococci, evolution of hyperinvasive meningococcal lineages, coverage of serogroup B vaccines towards Chinese meningococci, and molecular epidemiological surveillance of group A Streptococcus in China.
(#, co-first author; *, correspondence author) (research gate: 12111010069@fudan.edu.cn, Mingliang Chen)
- Chen ML, Zhang C, Zhang X, Chen M*. Meningococcal quinolone resistance originated from several commensal Neisseria species. Antimicrob Agents Chemother, 2020, 64(2):e01494-19. (IF= 4.904)
- Shen Y, Chen ML*. Prevalence, sequence type, and quinolone resistance of Neisseria lactamica carried in children younger than 15 years in Shanghai, China. J Infect, 2020, 80(1): 61-68 (IF= 4.842)
- Chen ML#, Cai J#, Davies M.R., Li Y, Zhang C, Yao W, Kong D, Pana H, Zhang X, Chen M*, Zeng M*. Increase of emm1 isolates among group A Streptococcus strains causing scarlet fever in Shanghai, China. Int J Infect Dis 2020, 98:305-314 (IF= 3.202)
- Chen ML*, Rodrigues CMC, Harrison OB, Zhang C, Tan T, Chen J, Zhang X, Chen M*, Maiden MCJ*. Invasive meningococcal disease in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation. Scientific Reports 2018, 8(1):12334 (IF=4.011)
- Shen Y#, Cai J#, Davies M.R., Zhang C, Gao K, Qiao D, Jiang H, Yao W, Li Y, Zeng M*, Chen ML*. Identification and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes clones harboring tetracycline and macrolide resistance in Shanghai, China. Frontiers in Microbiology 2018, 9:542 (IF= 4.259)
- Chen ML#, Wang W#, Tu L, Zheng Y, Pan H, Wang G, Chen Y, Zhang X, Zhu L, Chen J*, Chen M*. An emm5 Group A Streptococcal Outbreak Among Workers in a Factory Manufacturing Telephone Accessories. Frontiers in Microbiology 2017, 8:1156. (IF=4.019)
- Jiang H#, Chen ML#, Li T, Liu H, Gong Y, Li M. Molecular Characterization of Streptococcus agalactiae Causing Community- and Hospital-Acquired Infections in Shanghai, China. Frontiers in Microbiology. 2016, 7: 1308 (IF=4.076)
- Chen ML#, Guo Q#, Wang Y, Zou Y, Wang G, Zhang X, Xu X, Zhao M, Hu F, Qu D*, Chen M*, Wang M*. Shifts in the antibiotic susceptibility, serogroups, and clonal complexes of Neisseria meningitidis in Shanghai, China: A time trend analysis of the Pre-Quinolone and Quinolone Eras. PLoS medicine. 2015, 12(6):e1001838 (IF=13.585)
- Chen M#, Yao W#, Wang X, Li Y, Wang G, Zhang X, Pan H, Hu J*, Zeng M*. Outbreak of Scarlet Fever Associated with emm12 Type Group A Streptococcus in 2011 in Shanghai, China. Pediatr Infect Dis J. 2012, 31(9): e158-162. (IF=3.569)